Annual report pursuant to Section 13 and 15(d)

Note 3 - Supplemental Balance Sheet and Cash Flow Information - Changes in Carrying Amount of Goodwill (Details)

v3.10.0.1
Note 3 - Supplemental Balance Sheet and Cash Flow Information - Changes in Carrying Amount of Goodwill (Details) - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Balance $ 579,026 $ 430,882
Acquisitions (Note 2) 19,096 147,484
Prior year acquisitions   1,809
Currency translation (232) (1,149)
Balance 597,890 579,026
Biotechnology [Member]    
Balance 254,930 108,723
Acquisitions (Note 2) 16,186 147,484
Prior year acquisitions  
Currency translation 759 (1,277)
Balance 271,875 254,930
Protein Platforms [Member]    
Balance 220,826 218,889
Acquisitions (Note 2)
Prior year acquisitions   1,809
Currency translation (815) 128
Balance 220,011 220,826
Diagnostics [Member]    
Balance 103,270 103,270
Acquisitions (Note 2) 2,910
Prior year acquisitions  
Currency translation (176)
Balance $ 106,004 $ 103,270